Status:
COMPLETED
New Pharmacological Treatment for Obstructive Sleep Apnea
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
20-80 years
Phase:
PHASE1
Brief Summary
This study will determine if mirtazapine, a unique antidepressant that does not disturb sleep, will improve obstructive sleep apnea (OSA). The design is randomized, crossover, double blind, and placeb...
Eligibility Criteria
Inclusion
- Known OSA mild to moderate
Exclusion
- On antidepressant or antipsychotic medications
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00108498
Start Date
October 1 2003
End Date
March 1 2007
Last Update
January 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malcom Randall VAMC
Gainesville, Florida, United States, 32608